U.S. to Increase Production of the Ebola Drug ZMapp, but May Not Meet Demand

Thursday, October 2, 2014 - 01:20 in Health & Medicine

Despite the new efforts, supplies of the drug, ZMapp, are expected to be limited to hundreds or thousands of treatment courses by early next year, which would not be nearly enough if the epidemic continues to spiral out of control.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net